[EN] OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES<br/>[FR] DÉRIVÉS DE PYRIMIDINE SUBSTITUÉS PAR UN HÉTÉROCYCLYLE ÉVENTUELLEMENT CONDENSÉS UTILES POUR LE TRAITEMENT DES MALADIES INFLAMMATOIRES, MÉTABOLIQUES, ONCOLOGIQUES ET AUTO-IMMUNES
申请人:NUEVOLUTION AS
公开号:WO2016020288A1
公开(公告)日:2016-02-11
Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
揭示了对核受体具有活性的化合物,包含这些化合物的药物组合物以及这些化合物在治疗中的用途。
Robust and Scalable Approach to 1,3-Disubstituted Pyridylcyclobutanes
作者:Oleksandr P. Demchuk、Oleksandr V. Hryshchuk、Bohdan V. Vashchenko、Dmytro S. Radchenko、Volodymyr O. Kovtunenko、Igor V. Komarov、Oleksandr O. Grygorenko
DOI:10.1002/ejoc.201901001
日期:2019.9.15
Robust and scalable synthesis of functionalized 1,3‐disubstituted pyridylcyclobutanes (including nicotine analogues) is developed, which relies on double alkylation of pyridylacetonitriles.